Ardelyx Inc (ARDX)

07:21 AM

Published on: 2026-02-14 15:20:11 - mfd.ru

07:21 AM

04:48 AM

Can Ardelyx Inc. stock outperform in a bear marketJuly 2025 News Drivers & Fast Moving Stock Watchlists - mfd.ru

04:48 AM

Feb 13, 2026

Ardelyx, Inc. (ARDX) Stock Analysis: Healthcare Innovator With Over 100% Potential Upside - DirectorsTalk Interviews

Feb 13, 2026

Feb 12, 2026

Ardelyx (ARDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Finviz

Feb 12, 2026

Feb 12, 2026

Ardelyx, Inc. $ARDX Shares Sold by New York State Common Retirement Fund - MarketBeat

Feb 12, 2026

Feb 12, 2026

Will Ardelyx Inc. stock recover faster than peersMarket Weekly Review & Low Drawdown Investment Strategies - mfd.ru

Feb 12, 2026

Feb 12, 2026

Ardelyx (ARDX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 12, 2026

Feb 11, 2026

Ardelyx, Inc. (ARDX) Reports Strong 2025 Revenue Growth, Updates 2026 Outlook - Finviz

Feb 11, 2026

Feb 11, 2026

Is Ardelyx Inc. stock a good pick for beginners2025 Biggest Moves & Long-Term Safe Investment Ideas - mfd.ru

Feb 11, 2026

Feb 10, 2026

10 Best Long Term Healthcare Stocks to Buy - Insider Monkey

Feb 10, 2026

Feb 09, 2026

Ardelyx, Inc. (ARDX) gains TD analysts support ahead of Q4 results - MSN

Feb 09, 2026

Feb 07, 2026

Trend Report: Is Ardelyx Inc stock a buy or sell2025 Geopolitical Influence & Reliable Price Breakout Alerts - baoquankhu1.vn

Feb 07, 2026

Feb 06, 2026

Ardelyx Patent Extends Tenapanor Franchise Planning Horizon To 2042 - Yahoo Finance

Feb 06, 2026

Feb 05, 2026

Ardelyx, Inc. to Host Conference Call for 2025 Financial Results and Business Update - Quiver Quantitative

Feb 05, 2026

Feb 05, 2026

Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 - The Manila Times

Feb 05, 2026

Feb 04, 2026

Assessing Ardelyx (ARDX) Valuation After Patent Extension And Pipeline Progress - simplywall.st

Feb 04, 2026

Feb 04, 2026

Ardelyx receives new patent for Tenapanor - Yahoo Finance

Feb 04, 2026

Feb 03, 2026

Raymond James reiterates Strong Buy on Ardelyx stock after patent news - Investing.com UK

Feb 03, 2026

Feb 03, 2026

Raymond James reiterates Strong Buy on Ardelyx stock after patent news By Investing.com - Investing.com South Africa

Feb 03, 2026

Feb 03, 2026

Ardelyx (ARDX) Secures New Patent for Tenapanor Formulations - GuruFocus

Feb 03, 2026

Feb 03, 2026

Ardelyx Receives New Patent for Tenapanor - The Manila Times

Feb 03, 2026

Feb 03, 2026

Ardelyx, Inc. Secures U.S. Patent for Tenapanor Formulations, Expiring November 2042 - Quiver Quantitative

Feb 03, 2026

Feb 03, 2026

New patent shields Ardelyx gut drugs IBSRELA, XPHOZAH until 2042 - stocktitan.net

Feb 03, 2026

Feb 02, 2026

Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results - Insider Monkey

Feb 02, 2026

Feb 01, 2026

Jefferies remains a buy on Ardelyx (ARDX) - MSN

Feb 01, 2026

Jan 30, 2026

Jefferies Remains a Buy on Ardelyx (ARDX) - Finviz

Jan 30, 2026

Jan 30, 2026

How Ardelyx’s Phase 3 IBSRELA Trial in Chronic Constipation Has Changed Its Investment Story At Ardelyx (ARDX) - simplywall.st

Jan 30, 2026

Jan 30, 2026

Y Intercept Hong Kong Ltd Grows Stock Position in Ardelyx, Inc. $ARDX - MarketBeat

Jan 30, 2026

Jan 29, 2026

Ardelyx (NASDAQ:ARDX) Earns Buy Rating from BTIG Research - MarketBeat

Jan 29, 2026

Jan 29, 2026

BTIG Reiterates Buy Rating on Ardelyx (ARDX) with Stable Price T - GuruFocus

Jan 29, 2026

Jan 29, 2026

Ardelyx begins phase 3 trial of IBSRELA for chronic constipation By Investing.com - Investing.com South Africa

Jan 29, 2026

Jan 28, 2026

Ardelyx Draws Zydus Interest As IBSRELA Trial And Valuation Gain Focus - Sahm

Jan 28, 2026

Jan 28, 2026

Is Ardelyx (ARDX) Pricing Reflect Its Strong Multi Year Share Price Performance - Yahoo Finance

Jan 28, 2026

Jan 28, 2026

How Ardelyx’s Phase 3 ACCEL Trial for IBSRELA in CIC Will Impact Ardelyx (ARDX) Investors - Yahoo Finance

Jan 28, 2026

Jan 28, 2026

Ardelyx Says First Patient Dosed in Phase 3 Trial of Chronic Idiopathic Constipation Treatment - marketscreener.com

Jan 28, 2026

Jan 28, 2026

What analysts say about Ardelyx Inc. stockJuly 2025 Earnings & Safe Capital Allocation Plans - mfd.ru

Jan 28, 2026

Jan 28, 2026

Ardelyx begins phase 3 trial of IBSRELA for chronic constipation - Investing.com

Jan 28, 2026

Jan 28, 2026

Ardelyx (ARDX) Begins Dosing in Phase 3 Trial for IBSRELA - GuruFocus

Jan 28, 2026

Jan 28, 2026

First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA - The Manila Times

Jan 28, 2026

Jan 28, 2026

Ardelyx IncEnrollment Expected Throughout 2026, Topline Data in 2027 - marketscreener.com

Jan 28, 2026

Jan 28, 2026

New 700-patient constipation drug trial begins, targeting 34M adults - stocktitan.net

Jan 28, 2026

Jan 27, 2026

Is It Too Late To Consider Ardelyx (ARDX) After The Recent Share Price Surge? - simplywall.st

Jan 27, 2026